Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective Corrigendum to Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain products ( Official Journal of the European Union L 290 of 6 November 2009 )

Vyhláška č. 1050/2009

Text language

Important dates

Declared: 19. decembra 2009
Approved: 19. decembra 2009

Documents and links

Corrigendum to Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain products

In the Annex to Regulation (EC) No 1050/2009:

—

under point (1) referring to Annex II to Regulation (EC) No 396/2005, under the combinations:

Azoxystrobin — code number 0244000:

for:

‘ ’,

read:

‘0,2’;

Azoxystrobin — code number 0255000:

for:

‘ ’,

read:

‘0,2’;

Indoxacarb as sum of the isomers S and R (F) — code number 0255000:

for:

‘ ’,

read:

‘0,02 (*)’;

Ioxynil, including its esters expressed as ioxynil (F) — code number 0211000:

for:

‘ ’,

read:

‘0,05 (*)’;

Thiacloprid (F) — code number 0255000

for:

‘ ’,

read:

‘0,02 (*)’;

—

under point (2)(a)(i) referring to Part A of Annex III to Regulation (EC) No 396/2005, under the combinations:

Fluopicolide — code number 0152000:

for:

‘ ’,

read:

‘0,01 (*)’;

Fluopicolide — code number 0211000:

for:

‘ ’,

read:

‘0,02’;

Fluopicolide — code number 0232990:

for:

‘ ’,

read:

‘0,01 (*)’;

Fluopicolide — code number 0234000:

for:

‘ ’,

read:

‘0,01 (*)’;

Fluopicolide — code number 0244000:

for:

‘ ’,

read:

‘0,01 (*)’;

—

under point (2)(b) referring to Part B of Annex III to Regulation (EC) No 396/2005:

for:

‘Famoxadone’,

read:

‘Fenbutatin oxide (F)’;

for:

‘Fenbutatin oxide (F)’,

read:

‘Famoxadone’;

under the combination Trifloxystrobin — code number 0154080:

for:

‘0,02 (*)’,

read:

‘2’.